GB201900527D0 - Bicyclic peptide ligands specific for integrin avb3 - Google Patents

Bicyclic peptide ligands specific for integrin avb3

Info

Publication number
GB201900527D0
GB201900527D0 GBGB1900527.1A GB201900527A GB201900527D0 GB 201900527 D0 GB201900527 D0 GB 201900527D0 GB 201900527 A GB201900527 A GB 201900527A GB 201900527 D0 GB201900527 D0 GB 201900527D0
Authority
GB
United Kingdom
Prior art keywords
peptide ligands
ligands specific
bicyclic peptide
integrin avb3
avb3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1900527.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BicycleTx Ltd
Original Assignee
BicycleTx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BicycleTx Ltd filed Critical BicycleTx Ltd
Priority to GBGB1900527.1A priority Critical patent/GB201900527D0/en
Publication of GB201900527D0 publication Critical patent/GB201900527D0/en
Priority to EP20701120.6A priority patent/EP3966233A1/en
Priority to JP2021540822A priority patent/JP2022518210A/ja
Priority to PCT/GB2020/050071 priority patent/WO2020148527A1/en
Priority to US17/422,935 priority patent/US20220064221A1/en
Priority to CN202080014773.9A priority patent/CN113439088A/zh
Ceased legal-status Critical Current

Links

GBGB1900527.1A 2019-01-15 2019-01-15 Bicyclic peptide ligands specific for integrin avb3 Ceased GB201900527D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1900527.1A GB201900527D0 (en) 2019-01-15 2019-01-15 Bicyclic peptide ligands specific for integrin avb3
EP20701120.6A EP3966233A1 (en) 2019-01-15 2020-01-15 Bicyclic peptide ligands specific for integrin alpha v beta 3
JP2021540822A JP2022518210A (ja) 2019-01-15 2020-01-15 インテグリンαvβ3に特異的な二環式ペプチドリガンド
PCT/GB2020/050071 WO2020148527A1 (en) 2019-01-15 2020-01-15 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR INTEGRIN αVβ3
US17/422,935 US20220064221A1 (en) 2019-01-15 2020-01-15 Bicyclic peptide ligands specific for integrin alpha-v-beta-3
CN202080014773.9A CN113439088A (zh) 2019-01-15 2020-01-15 整联蛋白αvβ3特异性的双环肽配体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1900527.1A GB201900527D0 (en) 2019-01-15 2019-01-15 Bicyclic peptide ligands specific for integrin avb3

Publications (1)

Publication Number Publication Date
GB201900527D0 true GB201900527D0 (en) 2019-03-06

Family

ID=65528151

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1900527.1A Ceased GB201900527D0 (en) 2019-01-15 2019-01-15 Bicyclic peptide ligands specific for integrin avb3

Country Status (6)

Country Link
US (1) US20220064221A1 (https=)
EP (1) EP3966233A1 (https=)
JP (1) JP2022518210A (https=)
CN (1) CN113439088A (https=)
GB (1) GB201900527D0 (https=)
WO (1) WO2020148527A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107148425B (zh) 2014-10-29 2021-08-03 拜斯科阿迪有限公司 对mt1-mmp特异性的双环肽配体
EP3645549A1 (en) 2017-06-26 2020-05-06 BicycleRD Limited Bicyclic peptide ligands with detectable moieties and uses thereof
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
CN111902429A (zh) 2018-02-23 2020-11-06 拜斯科技术开发有限公司 多聚体双环肽配体
IL279489B2 (en) 2018-06-22 2025-10-01 Bicycletx Ltd Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
WO2020128527A1 (en) 2018-12-21 2020-06-25 Bicyclerd Limited Bicyclic peptide ligands specific for pd-l1
US12492224B2 (en) 2018-12-21 2025-12-09 Bicycletx Limited Bicyclic peptide ligands specific for PD-L1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
GB201900528D0 (en) * 2019-01-15 2019-03-06 Bicyclerd Ltd Bicyclic peptide ligands specific for integrin AVB3
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
AU2021322934A1 (en) 2020-08-03 2023-03-30 Bicycletx Limited Peptide-based linkers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2653545A1 (en) 2008-02-05 2013-10-23 Bicycle Therapeutics Limited Methods and compositions
US9073974B2 (en) * 2009-12-21 2015-07-07 The Regents Of The University Of California RGD-containing cyclic peptides
US20140274759A1 (en) * 2013-03-15 2014-09-18 Bicycle Therapeutics Limited Modification of polypeptides
CN107148425B (zh) 2014-10-29 2021-08-03 拜斯科阿迪有限公司 对mt1-mmp特异性的双环肽配体
EP3645549A1 (en) * 2017-06-26 2020-05-06 BicycleRD Limited Bicyclic peptide ligands with detectable moieties and uses thereof
GB201810329D0 (en) * 2018-06-22 2018-08-08 Bicycletx Ltd Peptide ligands for binding to integrin avB3

Also Published As

Publication number Publication date
JP2022518210A (ja) 2022-03-14
EP3966233A1 (en) 2022-03-16
US20220064221A1 (en) 2022-03-03
CN113439088A (zh) 2021-09-24
WO2020148527A1 (en) 2020-07-23

Similar Documents

Publication Publication Date Title
GB201900528D0 (en) Bicyclic peptide ligands specific for integrin AVB3
GB201900527D0 (en) Bicyclic peptide ligands specific for integrin avb3
ZA202100442B (en) Bicyclic peptide ligands specific for nectin-4
IL287881A (en) Ox40-specific bicyclic peptide ligands
IL283873B1 (en) Bicyclic peptide ligands specific for MT1-MMP
SG11202106082TA (en) Bicyclic peptide ligands specific for mt1-mmp
GB201810329D0 (en) Peptide ligands for binding to integrin avB3
GB201820295D0 (en) Bicyclic peptide ligands specific for MT1-MMP
GB201820320D0 (en) Bicyclic peptide ligands specific for FAPalpha
GB201701770D0 (en) Bicyclic peptide ligands specific for integrin AVB3
GB201800598D0 (en) Bicycle peptide ligands specific for integrin AVB3
GB201918495D0 (en) Bicyclic peptide ligands specific for il-46
GB201904632D0 (en) Bicyclic peptide ligands specific for nectin-4
GB201905631D0 (en) Bicyclic peptide ligands specific for pd-l1
GB201904622D0 (en) Bicyclic peptide ligands specific for pd-l1
GB201904621D0 (en) Bicyclic peptide ligands specific for PD-L1
GB201918489D0 (en) Bicyclic peptide ligands specific for hsp90
GB201918496D0 (en) Bicyclic peptide ligands specific for klk5
GB201918497D0 (en) Bicyclic peptide ligands specific for klk7
GB201820956D0 (en) Bicyclic peptide ligands specific for pd-l1
GB201818499D0 (en) Bicyclic peptide ligands specific for nectin-4
GB201815684D0 (en) Bicyclic peptide ligands specific for nectin-4
GB201918488D0 (en) Bicyclic peptide ligands specific for chymase
HK40067672A (en) BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR INTEGRIN αVβ3
HK40067671A (en) BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR INTEGRIN αVβ3

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)